Correspondence on 'Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence'
- PMID: 33004326
- DOI: 10.1136/annrheumdis-2020-218921
Correspondence on 'Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence'
Keywords: ankylosing; osteoporosis; spondylitis; tumor necrosis factor inhibitors.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to 'Correspondence on "Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence" by Zhang et al.Ann Rheum Dis. 2022 Dec;81(12):e253. doi: 10.1136/annrheumdis-2020-218944. Epub 2020 Oct 1. Ann Rheum Dis. 2022. PMID: 33004327 No abstract available.
Comment on
-
Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence.Ann Rheum Dis. 2020 Oct;79(10):1327-1332. doi: 10.1136/annrheumdis-2019-216741. Epub 2020 Jul 13. Ann Rheum Dis. 2020. PMID: 32660979
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
